TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 106 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $387,417 | +25.1% | 10,214 | -19.8% | 0.00% | 0.0% |
Q1 2023 | $309,642 | -16.3% | 12,732 | -0.1% | 0.00% | 0.0% |
Q4 2022 | $370,115 | +10.8% | 12,745 | +14.4% | 0.00% | 0.0% |
Q3 2022 | $334,000 | -9.7% | 11,145 | +8.8% | 0.00% | 0.0% |
Q2 2022 | $370,000 | -21.4% | 10,245 | -6.0% | 0.00% | 0.0% |
Q1 2022 | $471,000 | -15.4% | 10,898 | -2.0% | 0.00% | 0.0% |
Q4 2021 | $557,000 | -19.0% | 11,125 | +2.9% | 0.00% | 0.0% |
Q3 2021 | $688,000 | -15.8% | 10,809 | -4.8% | 0.00% | -50.0% |
Q2 2021 | $817,000 | +5.0% | 11,350 | +7.6% | 0.00% | 0.0% |
Q1 2021 | $778,000 | -4.1% | 10,550 | -4.5% | 0.00% | 0.0% |
Q4 2020 | $811,000 | +30.2% | 11,050 | -2.6% | 0.00% | 0.0% |
Q3 2020 | $623,000 | +2.5% | 11,350 | +24.0% | 0.00% | 0.0% |
Q2 2020 | $608,000 | +14.1% | 9,150 | +5.1% | 0.00% | 0.0% |
Q1 2020 | $533,000 | -30.3% | 8,705 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $765,000 | -62.4% | 8,705 | -67.7% | 0.00% | -60.0% |
Q3 2019 | $2,034,000 | -13.8% | 26,957 | -2.4% | 0.01% | -37.5% |
Q2 2019 | $2,359,000 | -8.8% | 27,622 | +15.5% | 0.01% | -11.1% |
Q1 2019 | $2,586,000 | +299.1% | 23,925 | +262.7% | 0.01% | +350.0% |
Q4 2018 | $648,000 | 0.0% | 6,597 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $648,000 | -37.3% | 6,597 | -26.1% | 0.00% | -50.0% |
Q2 2018 | $1,033,000 | -25.9% | 8,922 | -36.8% | 0.00% | -20.0% |
Q1 2018 | $1,395,000 | -6.9% | 14,128 | -1.2% | 0.01% | 0.0% |
Q4 2017 | $1,498,000 | +30.6% | 14,306 | +40.4% | 0.01% | +25.0% |
Q3 2017 | $1,147,000 | +22.3% | 10,186 | +21.7% | 0.00% | 0.0% |
Q2 2017 | $938,000 | +3.4% | 8,372 | +7.7% | 0.00% | 0.0% |
Q1 2017 | $907,000 | -23.3% | 7,775 | -30.8% | 0.00% | -33.3% |
Q4 2016 | $1,183,000 | -9.6% | 11,234 | -5.1% | 0.01% | -14.3% |
Q3 2016 | $1,309,000 | +450.0% | 11,843 | +625.2% | 0.01% | +600.0% |
Q2 2016 | $238,000 | +13.3% | 1,633 | +11.5% | 0.00% | 0.0% |
Q1 2016 | $210,000 | +320.0% | 1,464 | +349.1% | 0.00% | – |
Q4 2015 | $50,000 | – | 326 | – | 0.00% | – |
Q3 2015 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
Q2 2015 | $54,000 | +1.9% | 376 | 0.0% | 0.00% | – |
Q1 2015 | $53,000 | -77.5% | 376 | -76.4% | 0.00% | -100.0% |
Q4 2014 | $236,000 | – | 1,595 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 650,089 | $27,954 | 12.84% |
Analyst IMS Investment Management Services Ltd. | 13,557 | $583 | 0.02% |
LRI Investments, LLC | 2,000 | $85,778 | 0.01% |
Gladius Capital Management LP | 761 | $32,701 | 0.00% |
RHUMBLINE ADVISERS | 12,625 | $542,490 | 0.00% |
Lindbrook Capital, LLC | 142 | $6,102 | 0.00% |
Covestor Ltd | 26 | $1 | 0.00% |
Red Tortoise LLC | 40 | $1,719 | 0.00% |
OSAIC HOLDINGS, INC. | 199 | $8,551 | 0.00% |
Parallel Advisors, LLC | 19 | $816 | 0.00% |